메뉴 건너뛰기




Volumn 43, Issue 7, 1997, Pages 1215-1222

Preparation of lyophilized partial thromboplastin time reagent composed of synthetic phospholipids: Usefulness for monitoring heparin therapy

Author keywords

Anticoagulants; Standardization

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CITRIC ACID; COUMARIN; DIOLEOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIOLEOYLPHOSPHATIDYLSERINE; HEPARIN; KAOLIN; PHOSPHOLIPID; PROTHROMBIN A; REAGENT; SILICON DIOXIDE; THROMBOPLASTIN;

EID: 0030836719     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.7.1215     Document Type: Article
Times cited : (20)

References (29)
  • 1
    • 0344961471 scopus 로고
    • The partial thromboplastin time (cephalin time) in anticoagulant therapy
    • Struver GP, Bittner DL. The partial thromboplastin time (cephalin time) in anticoagulant therapy. Am J Clin Pathol 1962;38: 473-81.
    • (1962) Am J Clin Pathol , vol.38 , pp. 473-481
    • Struver, G.P.1    Bittner, D.L.2
  • 2
    • 0024416374 scopus 로고
    • A comparison of two APTT reagents which use silica activators
    • Ray MJ, Hawson GAT. A comparison of two APTT reagents which use silica activators. Clin Lab Haematol 1989;11:221-32.
    • (1989) Clin Lab Haematol , vol.11 , pp. 221-232
    • Ray, M.J.1    Hawson, G.A.T.2
  • 4
    • 0028567316 scopus 로고
    • Activated partial thromboplastin time for automated techniques: A comparison of two commonly used reagents
    • Craig S, Stevenson KJ, Taberner DA. Activated partial thromboplastin time for automated techniques: a comparison of two commonly used reagents. Br J Biomed Sci 1994;51:321-7.
    • (1994) Br J Biomed Sci , vol.51 , pp. 321-327
    • Craig, S.1    Stevenson, K.J.2    Taberner, D.A.3
  • 5
    • 0030014877 scopus 로고    scopus 로고
    • The therapeutic range for heparin therapy: Relationship between six activated partial thromboplastin time reagents and two heparin assays
    • Kitchen S, Preston FE. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays. Thromb Haemost 1996;75: 734-9.
    • (1996) Thromb Haemost , vol.75 , pp. 734-739
    • Kitchen, S.1    Preston, F.E.2
  • 6
    • 51849182567 scopus 로고
    • Use of the activated partial thromboplastin time for monitoring heparin therapy: Problems and possible solutions
    • Poller L, Thomson JM, Taberner DA. Use of the activated partial thromboplastin time for monitoring heparin therapy: problems and possible solutions. Res Clin Lab 1989;19:363-70.
    • (1989) Res Clin Lab , vol.19 , pp. 363-370
    • Poller, L.1    Thomson, J.M.2    Taberner, D.A.3
  • 7
    • 0027092654 scopus 로고
    • An attempt to standardize APTT reagents used to monitor heparin therapy
    • Ray M, Carroll P, Smith I, Hawson G. An attempt to standardize APTT reagents used to monitor heparin therapy. Blood Coag Fibrinol 1992;3:743-8.
    • (1992) Blood Coag Fibrinol , vol.3 , pp. 743-748
    • Ray, M.1    Carroll, P.2    Smith, I.3    Hawson, G.4
  • 8
    • 0028356281 scopus 로고
    • An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study
    • Reed SV, Haddon ME, Denson KWE. An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study. Thromb Res 1994;74: 515-22.
    • (1994) Thromb Res , vol.74 , pp. 515-522
    • Reed, S.V.1    Haddon, M.E.2    Denson, K.W.E.3
  • 9
    • 0028878422 scopus 로고
    • The APTT monitoring of heparin - The ISTH/ICSH collaborative study
    • Van der Velde EA, Poller L. The APTT monitoring of heparin - the ISTH/ICSH collaborative study. Thromb Haemost 1995;73:73-81.
    • (1995) Thromb Haemost , vol.73 , pp. 73-81
    • Van Der Velde, E.A.1    Poller, L.2
  • 10
    • 0030057043 scopus 로고    scopus 로고
    • Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage
    • Kitchen S, Jennings I, Woods TAL, Preston FE. Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage. J Clin Pathol 1996;49:10-4.
    • (1996) J Clin Pathol , vol.49 , pp. 10-14
    • Kitchen, S.1    Jennings, I.2    Woods, T.A.L.3    Preston, F.E.4
  • 11
    • 0027732256 scopus 로고
    • Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparin
    • Van den Besselaar AMHP, Neuteboom J, Bertina RM. Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparin. Blood Coag Fibrinol 1993;4:895-903.
    • (1993) Blood Coag Fibrinol , vol.4 , pp. 895-903
    • Van Den Besselaar, A.M.H.P.1    Neuteboom, J.2    Bertina, R.M.3
  • 12
    • 0028210230 scopus 로고
    • Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids
    • Bader R, Mannucci PM, Tripodi A, Hirsh J, Keller F, Solleder EM, et al. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemost 1994;71:292-9.
    • (1994) Thromb Haemost , vol.71 , pp. 292-299
    • Bader, R.1    Mannucci, P.M.2    Tripodi, A.3    Hirsh, J.4    Keller, F.5    Solleder, E.M.6
  • 13
    • 0018835636 scopus 로고
    • Heparin and partial thromboplastin time: An international survey
    • Poller L, Thomson JM, Yee KF. Heparin and partial thromboplastin time: an international survey. Br J Haematol 1980;44:161-5.
    • (1980) Br J Haematol , vol.44 , pp. 161-165
    • Poller, L.1    Thomson, J.M.2    Yee, K.F.3
  • 14
    • 0020027425 scopus 로고
    • Preparation of a stable phospholipid reagent for coagulation assays
    • Barrowcliffe TW, Stocks J, Gray E. Preparation of a stable phospholipid reagent for coagulation assays. Haemostasis 1982;11: 96-101.
    • (1982) Haemostasis , vol.11 , pp. 96-101
    • Barrowcliffe, T.W.1    Stocks, J.2    Gray, E.3
  • 15
    • 0027209887 scopus 로고
    • Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing
    • Van den Besselaar AMHP, Meeuwisse-Braun J. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing. Blood Coag Fibrinol 1993;4: 635-8.
    • (1993) Blood Coag Fibrinol , vol.4 , pp. 635-638
    • Van Den Besselaar, A.M.H.P.1    Meeuwisse-Braun, J.2
  • 16
    • 0025174959 scopus 로고
    • Monitoring heparin therapy: Relationships between the activated partial thromboplastin time and heparin assays based on ex-vivo heparin samples
    • Van den Besselaar AMHP, Meeuwisse-Braun J, Bertina RM. Monitoring heparin therapy: relationships between the activated partial thromboplastin time and heparin assays based on ex-vivo heparin samples. Thromb Haemost 1990;63:16-23.
    • (1990) Thromb Haemost , vol.63 , pp. 16-23
    • Van Den Besselaar, A.M.H.P.1    Meeuwisse-Braun, J.2    Bertina, R.M.3
  • 17
    • 8544224663 scopus 로고
    • Use of synthetic phospholipids in an APTT reagent for monitoring treatment with heparin
    • Neuteboom J, Van den Besselaar AMHP, Bertina RM. Use of synthetic phospholipids in an APTT reagent for monitoring treatment with heparin [Abstract]. Thromb Haemost 1991;65: 906.
    • (1991) Thromb Haemost , vol.65 , pp. 906
    • Neuteboom, J.1    Van Den Besselaar, A.M.H.P.2    Bertina, R.M.3
  • 18
    • 73049137829 scopus 로고
    • The effect of colloidal silica on blood coagulation
    • Margolis J. The effect of colloidal silica on blood coagulation. Aust J Exp Biol 1961;39:249-58.
    • (1961) Aust J Exp Biol , vol.39 , pp. 249-258
    • Margolis, J.1
  • 19
    • 0022639295 scopus 로고
    • Partial thromboplastin time test - Proposed performance guidelines
    • Koepke JA. Partial thromboplastin time test - proposed performance guidelines. Thromb Haemost 1986;55:143-4.
    • (1986) Thromb Haemost , vol.55 , pp. 143-144
    • Koepke, J.A.1
  • 20
    • 0013632115 scopus 로고
    • The activated partial thromboplastin time
    • Thomson JM, ed. Edinburgh: Churchill Livingstone
    • Thomson JM, Poller L. The activated partial thromboplastin time. In: Thomson JM, ed. Blood coagulation and haemostasis, a practical guide. Edinburgh: Churchill Livingstone, 1985;301-39.
    • (1985) Blood Coagulation and Haemostasis, a Practical Guide , pp. 301-339
    • Thomson, J.M.1    Poller, L.2
  • 21
    • 0026055774 scopus 로고
    • One-step chromogenic equivalent of activated partial thromboplastin time evaluated for clinical application
    • Ponjee GAE, Vader HL, de Wild PJ, Janssen GWT, van der Graaf F. One-step chromogenic equivalent of activated partial thromboplastin time evaluated for clinical application. Clin Chem 1991; 37:1235-44.
    • (1991) Clin Chem , vol.37 , pp. 1235-1244
    • Ponjee, G.A.E.1    Vader, H.L.2    De Wild, P.J.3    Janssen, G.W.T.4    Van Der Graaf, F.5
  • 22
    • 0024449513 scopus 로고
    • Randomized study of adjusted versus fixed-dose heparin prophylaxis of deep vein thrombosis in hip surgery
    • Taberner DA, Poller L, Thomson JM, Lemon G, Weighill FJ. Randomized study of adjusted versus fixed-dose heparin prophylaxis of deep vein thrombosis in hip surgery. Br J Surg 1989;76: 933-5.
    • (1989) Br J Surg , vol.76 , pp. 933-935
    • Taberner, D.A.1    Poller, L.2    Thomson, J.M.3    Lemon, G.4    Weighill, F.J.5
  • 23
    • 0020501831 scopus 로고
    • Adjusted versus fixed dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement
    • Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvard J, Livio J. Adjusted versus fixed dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 1983;309:954-8.
    • (1983) N Engl J Med , vol.309 , pp. 954-958
    • Leyvraz, P.F.1    Richard, J.2    Bachmann, F.3    Van Melle, G.4    Treyvard, J.5    Livio, J.6
  • 24
    • 0023003183 scopus 로고
    • Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis
    • Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315:1109-14.
    • (1986) N Engl J Med , vol.315 , pp. 1109-1114
    • Hull, R.D.1    Raskob, G.E.2    Hirsh, J.3    Jay, R.M.4    Leclerc, J.R.5    Geerts, W.H.6
  • 25
    • 0025009152 scopus 로고
    • Subcutaneous vs intravenous heparin in the treatment of deep-venous thrombosis. A randomized clinical trial
    • Pini M, Pattacini C, Quintavalla R, Poli T, Megha A, Tagliaferri A, et al. Subcutaneous vs intravenous heparin in the treatment of deep-venous thrombosis. A randomized clinical trial. Thromb Haemost 1990;64:222-6.
    • (1990) Thromb Haemost , vol.64 , pp. 222-226
    • Pini, M.1    Pattacini, C.2    Quintavalla, R.3    Poli, T.4    Megha, A.5    Tagliaferri, A.6
  • 26
    • 0028118694 scopus 로고
    • A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin
    • Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, et al. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 1994;154:49-56.
    • (1994) Arch Intern Med , vol.154 , pp. 49-56
    • Levine, M.N.1    Hirsh, J.2    Gent, M.3    Turpie, A.G.4    Cruickshank, M.5    Weitz, J.6
  • 27
    • 0021189964 scopus 로고
    • The antithrombotic effect of heparin in deep venous thrombosis: Relation to four heparin assays
    • Holm HA, Abildgaard U, Kalvenes S, Anderssen N, Anker E, Arnesen KE, et al. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays. Acta Med Scand 1984;216:287-93.
    • (1984) Acta Med Scand , vol.216 , pp. 287-293
    • Holm, H.A.1    Abildgaard, U.2    Kalvenes, S.3    Anderssen, N.4    Anker, E.5    Arnesen, K.E.6
  • 28
    • 0021880148 scopus 로고
    • Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding
    • Holm HA, Abildgaard U, Kalvenes S. Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding. Thromb Haemost 1985;53:278-81.
    • (1985) Thromb Haemost , vol.53 , pp. 278-281
    • Holm, H.A.1    Abildgaard, U.2    Kalvenes, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.